1. Home
  2. IQV vs KMB Comparison

IQV vs KMB Comparison

Compare IQV & KMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$230.79

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Logo Kimberly-Clark Corporation

KMB

Kimberly-Clark Corporation

HOLD

Current Price

$109.05

Market Cap

34.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IQV
KMB
Founded
1982
1910
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
36.4B
34.2B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
IQV
KMB
Price
$230.79
$109.05
Analyst Decision
Buy
Hold
Analyst Count
17
12
Target Price
$236.71
$129.58
AVG Volume (30 Days)
1.4M
8.6M
Earning Date
10-28-2025
10-30-2025
Dividend Yield
N/A
4.62%
EPS Growth
N/A
N/A
EPS
7.30
5.91
Revenue
$15,904,000,000.00
$19,724,000,000.00
Revenue This Year
$6.14
N/A
Revenue Next Year
$5.28
$3.10
P/E Ratio
$31.49
$18.47
Revenue Growth
3.85
11.62
52 Week Low
$134.65
$99.22
52 Week High
$234.30
$150.45

Technical Indicators

Market Signals
Indicator
IQV
KMB
Relative Strength Index (RSI) 68.05 51.38
Support Level $228.69 $101.76
Resistance Level $234.30 $109.80
Average True Range (ATR) 5.76 2.04
MACD 0.89 1.24
Stochastic Oscillator 83.07 92.31

Price Performance

Historical Comparison
IQV
KMB

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About KMB Kimberly-Clark Corporation

With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It intends to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.

Share on Social Networks: